From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems

J Yang, D Li, M Zhang, G Lin, S Hu, H Xu - Journal of Controlled Release, 2023 - Elsevier
Inflammatory bowel diseases (IBDs) treatments have shifted from small-molecular
therapeutics to the oncoming biologics. The first-line biologics against the moderate-to …

Fibrogenesis in Crohn's disease

JP Burke, JJ Mulsow, C O'keane… - Official journal of the …, 2007 - journals.lww.com
METHODS The electronic literature (January 1966 to May 2006) on CD-associated fibrosis
was reviewed. Further references were obtained by cross-referencing from key articles …

MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function

LB McKenna, J Schug, A Vourekas, JB McKenna… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Whereas the importance of microRNA (miRNA) for the
development of several tissues is well established, its role in the intestine is unknown. We …

Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis

SN Flier, H Tanjore, EG Kokkotou, H Sugimoto… - Journal of Biological …, 2010 - ASBMB
Intestinal fibrosis is a major complication of Crohn disease (CD), but the precise mechanism
by which it occurs is incompletely understood. As a result, specific therapies to halt or even …

Bone morphogenetic proteins and their antagonists: current and emerging clinical uses

IHA Ali, DP Brazil - British journal of pharmacology, 2014 - Wiley Online Library
Bone morphogenetic proteins (BMPs) are members of the TGF β superfamily of secreted
cysteine knot proteins that includes TGF β1, nodal, activins and inhibins. BMPs were first …

Recent developments on BMPs and their antagonists in inflammatory bowel diseases

Z Xie, G Zhou, M Zhang, J Han, Y Wang, X Li… - Cell Death …, 2023 - nature.com
Inflammatory bowel diseases (IBDs), including ulcerative colitis, and Crohn's disease, are
intestinal disorders characterized by chronic relapsing inflammation. A large proportion of …

The life and death of epithelia during inflammation: lessons learned from the gut

S Koch, A Nusrat - Annual Review of Pathology: Mechanisms of …, 2012 - annualreviews.org
Epithelial cells form protective barriers that physically separate an organism from the outside
world. Rather than being merely static, impregnable shields, epithelia are highly dynamic …

Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing

K Krishnan, B Arnone, A Buchman - Inflammatory bowel …, 2011 - academic.oup.com
Background A key feature of inflammatory bowel disease (IBD) is impaired epithelial repair.
Human growth factors comprise an array of signaling molecules that lead to ligand-specific …

Smad6 negatively regulates interleukin 1-receptor–Toll-like receptor signaling through direct interaction with the adaptor Pellino-1

KC Choi, YS Lee, S Lim, HK Choi, CH Lee, EK Lee… - Nature …, 2006 - nature.com
Transforming growth factor-β1 (TGF-β1) is a potent cytokine with pleiotropic effects,
including anti-inflammatory activity. Here we show that the signaling protein Smad6 bound …

Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-β1 in normal human lung fibroblasts (NHLF)

S Pegorier, GA Campbell, AB Kay, CM Lloyd - Respiratory research, 2010 - Springer
Background Airway remodelling is thought to be under the control of a complex group of
molecules belonging to the Transforming Growth Factor (TGF)-superfamily. The Bone …